STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance

RecarbioNegative

AI Analysis

Summary

Merck has discontinued Recarbio, an antibiotic marketed in the U.S., amid ongoing concerns about resistance to multidrug-resistant bacteria. The discontinuation raises questions about antibiotic availability in the market.

Outcome Details

Product discontinuation

Importance:5/10

Sentiment:

-0.70

product discontinuationantibioticantimicrobial resistancepublic health concern

Related Companies

$MRK

Read the original article

Published by STAT News on September 28, 2026 8:45 PM

Read Original